Ron Branning has been appointed senior vice president of Global Product Quality, Genzyme. In this role, he will ensure the quality of all Genzyme products manufactured at 17 sites around the world. Mr. Branning will report to Genzyme executive vice president David Meeker, M.D., and chief executive officer, Henri Termeer. “We are committed to the highest standards of drug and device quality for patients,” said Mr. Termeer. “Ron Branning is a recognized industry leader in ensuring product quali...